These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15554765)

  • 1. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    Nickel MK; Nickel C; Mitterlehner FO; Tritt K; Lahmann C; Leiberich PK; Rother WK; Loew TH
    J Clin Psychiatry; 2004 Nov; 65(11):1515-9. PubMed ID: 15554765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.
    Nickel MK; Nickel C; Kaplan P; Lahmann C; Mühlbacher M; Tritt K; Krawczyk J; Leiberich PK; Rother WK; Loew TH
    Biol Psychiatry; 2005 Mar; 57(5):495-9. PubMed ID: 15737664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.
    Loew TH; Nickel MK; Muehlbacher M; Kaplan P; Nickel C; Kettler C; Fartacek R; Lahmann C; Buschmann W; Tritt K; Bachler E; Mitterlehner F; Pedrosa Gil F; Leiberich P; Rother WK; Egger C
    J Clin Psychopharmacol; 2006 Feb; 26(1):61-6. PubMed ID: 16415708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up.
    Nickel MK; Loew TH
    Eur Psychiatry; 2008 Mar; 23(2):115-7. PubMed ID: 18024088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.
    Tritt K; Nickel C; Lahmann C; Leiberich PK; Rother WK; Loew TH; Nickel MK
    J Psychopharmacol; 2005 May; 19(3):287-91. PubMed ID: 15888514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.
    Nickel C; Lahmann C; Tritt K; Muehlbacher M; Kaplan P; Kettler C; Krawczyk J; Loew TH; Rother WK; Nickel MK
    J Affect Disord; 2005 Aug; 87(2-3):243-52. PubMed ID: 15985295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduced aggression in female patients with borderline personality disorder.
    Nickel M
    Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):432-3. PubMed ID: 17902007
    [No Abstract]   [Full Text] [Related]  

  • 12. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Zanarini MC; Frankenburg FR
    Am J Psychiatry; 2003 Jan; 160(1):167-9. PubMed ID: 12505817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.
    Muehlbacher M; Nickel MK; Kettler C; Tritt K; Lahmann C; Leiberich PK; Nickel C; Krawczyk J; Mitterlehner FO; Rother WK; Loew TH; Kaplan P
    Clin J Pain; 2006; 22(6):526-31. PubMed ID: 16788338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate treatment of aggression in male borderline patients.
    Nickel MK
    Aust N Z J Psychiatry; 2007 May; 41(5):461-2. PubMed ID: 17464743
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up.
    Leiberich P; Nickel MK; Tritt K; Pedrosa Gil F
    J Psychopharmacol; 2008 Sep; 22(7):805-8. PubMed ID: 18308777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC; Schulz SC; Detke HC; Tanaka Y; Zhao F; Lin D; Deberdt W; Kryzhanovskaya L; Corya S
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study.
    Nickel MK; Nickel C; Muehlbacher M; Leiberich PK; Kaplan P; Lahmann C; Tritt K; Krawczyk J; Kettler C; Egger C; Rother WK; Loew TH
    J Clin Psychopharmacol; 2005 Jun; 25(3):211-7. PubMed ID: 15876898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM; McDavid JD; Brown MZ; Sayrs JH; Gallop RJ
    J Clin Psychiatry; 2008 Jun; 69(6):999-1005. PubMed ID: 18466045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.